HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: t
View:

• Self-identifies as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum)

• Report sex with a cisgender man or transgender woman or any individual assigned male sex at birth in the past 12 months

• Age 15 years or older

• Willing and able to provide written informed consent

• Owns an iOS or Android mobile phone and able to access the internet and send and receive text messages

• Able to understand, read, and speak English or Spanish

• Newly initiated PrEP or currently on PrEP and at risk for PrEP discontinuation based on at least one of the following:

‣ Initiated PrEP within the past 6 months, or

⁃ Has any of the following risk factors for PrEP discontinuation: missed clinic visits; age \< 30; African-American or Latino; transgender gender identity; or self-reported illicit substance use

Locations
United States
California
Bridge HIV, San Francisco Department of Public Health
ACTIVE_NOT_RECRUITING
San Francisco
San Francisco AIDS Foundation
RECRUITING
San Francisco
Washington, D.c.
Whitman-Walker Health
RECRUITING
Washington D.c.
Florida
University of Miami
RECRUITING
Miami
Time Frame
Start Date: 2021-07-21
Estimated Completion Date: 2023-08
Participants
Target number of participants: 300
Treatments
Experimental: PrEPmate
Participants randomized to this study arm will receive the PrEPmate mHealth intervention (bi-directional text messaging with PrEP navigators/clinic staff) to support PrEP adherence and continuation.
Experimental: Dot Diary mobile application
Participants randomized to this study arm will download and use the Dot Diary mobile application on a personal device, to support PrEP adherence and continuation.
Related Therapeutic Areas
Sponsors
Leads: Public Health Foundation Enterprises, Inc.
Collaborators: San Francisco AIDS Foundation, University of Miami, San Francisco Department of Public Health, Whitman-Walker Health, University of California, San Francisco, WelTel, Patient-Centered Outcomes Research Institute

This content was sourced from clinicaltrials.gov